Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
13 August 2010Website:
http://smartvest.comNext earnings report:
22 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 05 Jul 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
ELMD Latest News
Electromed reported an impressive quarter and expects beneficial results for 2024, with a total market opportunity of 4.2 million Bronchiectasis patients. The company's growth strategies, including direct-to-consumer marketing and internationalization efforts, could drive significant net sales growth. Electromed's stock repurchase program and recent price dynamics make it an attractive investment opportunity.
Electromed, Inc. (ELMD) Q2 2024 Earnings Call Transcript
Electromed, Inc. (NYSE:ELMD ) Q1 2024 Results Conference Call November 7, 2023 5:00 PM ET Company Participants Mike Cavanaugh - IR, ICR Westwicke Jim Cunniff - President and CEO Brad Nagel - CFO Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Good day, and welcome to the Electromed First Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note today's event is being recorded.
Electromed continues to rally off previous lows and crossed above the 50DMA last week. SmartVest numbers are ratcheting higher, CMS waiver decision well priced into the equity level.
Electromed, Inc. (NYSE:ELMD ) Q3 2023 Results Conference Call May 9, 2023 5:00 PM ET Company Participants Mike Cavanaugh - Investor Relations Kathleen Skarvan - President and Chief Executive Officer Brad Nagel - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Operator Welcome to the Electromed Third Quarter Fiscal 2023 Financial Results Conference Call [Operator Instructions]. I will now turn the call over to your host, Mike Cavanaugh, Investor Relations.
What type of business is Electromed?
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.
What sector is Electromed in?
Electromed is in the Healthcare sector
What industry is Electromed in?
Electromed is in the Medical Devices industry
What country is Electromed from?
Electromed is headquartered in United States
When did Electromed go public?
Electromed initial public offering (IPO) was on 13 August 2010
What is Electromed website?
https://smartvest.com
Is Electromed in the S&P 500?
No, Electromed is not included in the S&P 500 index
Is Electromed in the NASDAQ 100?
No, Electromed is not included in the NASDAQ 100 index
Is Electromed in the Dow Jones?
No, Electromed is not included in the Dow Jones index
When does Electromed report earnings?
The next expected earnings date for Electromed is 22 August 2024